Literature DB >> 7391586

Antibody-dependent cell-mediated cytolysis (ADCC) with antibody-coated effectors: new methods for enhancing antibody binding and cytolysis.

J F Jones, D M Segal.   

Abstract

When P388D1 cells are incubated with anti-TNP IgG antibody and centrifuged through a mixture of dibutylphthalate and bis-(2-ethylhexyl)phthalate (1.5:1), large amounts of antibody remain cell bound for at least 20 hr after washing. Incubating cells with antibody in various concentrations of polyethylene glycol also enhances antibody binding compared with control cells incubated with antibody alone. P388D1 cells coated with anti-TNP antibody are potent killers of TNP-conjugated chicken erythrocytes (not coated with antibody). The cytolytic activity increases in proportion to the amount of antibody bound by the effector cells. Lysis is antibody dependent and hapten inhibitable. When mediated by antibody-coated effectors, lysis is less suceptible to inhibition by aggregated IgG than lysis of antibody-coated cells mediated by untreated effector cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7391586

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.

Authors:  G Schulz; T F Bumol; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

2.  Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.

Authors:  P Perez; R W Hoffman; J A Titus; D M Segal
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

3.  Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.

Authors:  Aurélie Poli; Jian Wang; Olivia Domingues; Jesús Planagumà; Tao Yan; Cecilie Brekke Rygh; Kai Ove Skaftnesmo; Frits Thorsen; Emmet McCormack; François Hentges; Paal Henning Pedersen; Jacques Zimmer; Per Øyvind Enger; Martha Chekenya
Journal:  Oncotarget       Date:  2013-09

4.  Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.

Authors:  B Karpovsky; J A Titus; D A Stephany; D M Segal
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.